100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

CACA-SPCC-OncoDaily Summit 2025: Advancing Global Collaboration in Cancer Care

CACA-SPCC-OncoDaily

ASCO Election 2025: Meet the Candidates for Leadership Positions

ASCO Election 2025-OncoDaily

Allo-iNKT Therapy in PD-1–Refractory Solid Tumors: SITC25 - MiNK Therapeutics

Allo-iNKT Therapy in PD-1–Refractory Solid Tumors: SITC25 - MiNK Therapeutics

Tilly Metz: 20 Years of Collaboration to Phase Out Animal Testing

Tilly Metz: 20 Years of Collaboration to Phase Out Animal Testing

Douglas Flora: Why Time Doesn't Heal All Wounds - But It Does Make Them Bearable

Douglas Flora

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

OncoCalendar

Loading Events

« All Events

  • This event has passed.

The 7th National Congress of the Tunisian Society of Radiation Oncology (STOR)

Jun 27 • 8:00 AM - Jun 28 • 5:00 PM
The 7th National Congress of the Tunisian Society of Radiation Oncology

The 7th National Congress of the Tunisian Society of Radiation Oncology (STOR) endorsed by ESTRO will be held from June 27-28, 2025 at Sfax.

This year’s theme, “Collaborations and Innovations in Radiotherapy,” emphasizes the importance of combining expertise and innovation to tackle the challenges faced in radiotherapy. The congress will feature a comprehensive scientific program, with sessions on topics like extracranial stereotaxy, the combination of radiotherapy and systemic treatments, thromboembolic disease and cancer, radiotherapy ethics, and new advancements in Tunisia. Attendees will explore cutting-edge research and practice-changing trials to improve patient care and outcomes.

Abstract Submission is until March 15, 2025.

Registration is open for the event.

Venue